Search

Search Constraints

You searched for: Author/Creator Mapara, Markus Y.

Search Results

1. Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma. (16th December 2016)

3. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Issue 6 (June 2021)

5. Effect of Ex Vivo–Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques. Issue 2 (February 2017)

6. Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis. Issue 7 (14th April 2022)

8. Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma. Issue 1 (January 2015)

9. Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trial. Issue 9 (3rd June 2020)